Pune, June 02, 2023 (GLOBE NEWSWIRE) -- A global Healthcare research and business consulting firm, Maximize Market Research, has published a market intelligence report on the “HER 2 testing Market”. The report is a combination of primary data and secondary data and domain experts have analyzed the HER 2 testing Market from a local as well as a global point of view. Over the forecast period, Maximize Market Research expects the market to grow from USD 136.04 Mn in 2022 to USD 221.32 Mn in 2029 at a CAGR of 7.2 percent.
HER 2 testing Market Report Scope and Research Methodology
| Market Size in 2022 | USD 136.04 Mn. |
| Market Size in 2029 | USD 221.32 Mn. |
| CAGR | 7.2 percent (2023-2029) |
| Forecast Period | 2023-2029 |
| Base Year | 2022 |
| Number of Pages | 276 |
| No. of Tables | 113 |
| No. of Charts and Figures | 112 |
| Segment Covered | Product, Cancer Type, and End-Users |
| Regional Scope | North America, Europe, Asia Pacific, Middle East and Africa, South America |
| Report Coverage | Market Share, Size & Forecast by Revenue | 2022−2029, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, MMR Competition Matrix, Competitive Leadership Mapping, Global Key Players’ Market Ranking Analysis. |
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/188548
The research methodology includes primary research, secondary research, and industry expertise. Primary research includes collecting of data through interviews, surveys, and reviews of the industry analysts. Secondary research contains desk-based research like data points collected from available database sources, other external sources, and internal and external proprietary databases. Industry expert reviews contain insights from relevant experts from the industry. After the collection of the data primary and secondary research methodology. The data is then validated through the triangulation method. The market size estimation calculations are calculated through a top-down approach. The research covers the detailed analysis of the market trends, new technology, foreign entrance, new rules, government investment, new uses. It also contains a comprehensive trend analysis, which helps to make business decisions in the HER 2 testing market. The report covers the detailed analysis with an overview of the market, current and future growth prospects, as well as other growth methods employed by key companies to keep ahead of the competition.
HER 2 testing Market Overview
HER2 stands for human epidermal growth factor receptor 2. It is a genetic factor that makes a protein found on the surface of all breast cells. In cancer disease detection, cancers with high levels of the HER2 protein are called HER2-positive. HER2 testing is typically used to find out whether cancer is HER2-positive. It is also used to get if the cancer is responding to treatment or if the cancer has been reimbursed after treatment. Most HER2 testing contains taking a sample of tumor tissue in a process called a biopsy.
HER 2 testing Market Dynamics
The HER2 testing market growth is driven by some of the prominent factors like technological advancements, developing guidelines, and growing demand for personalized medicine The testing is mainly used in the diagnosis and treatment of breast cancer patients. The HER2 testing market has witnessed substantial developments in HER2 testing technologies. In the testing approach, immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) were used traditionally. In recent years, innovative technologies like newer techniques such as next-generation sequencing (NGS) and gene expression profiling are gaining prominence. The advanced technologies deliver higher sensitivity, specificity, and accuracy in HER2 testing, empowering better patient management. An increase in focus on personalized medicine is expected to drive the demand for HER2 testing. By the analysis of the HER 2 testing, HER2-positive breast cancer patients are assisted by targeted therapies like trastuzumab (Herceptin) and pertuzumab (Perjeta). Accurate HER2 testing is required to identify patients, who are expected to respond to the targeted treatments that are leading to improve clinical outcomes.
Get a Sample Copy of the Report : https://www.maximizemarketresearch.com/request-sample/188548
HER 2 testing Market Regional Insights
North America region held the dominant position in the HER 2 testing Market
North America region has accounted for maximum share in 2022, thanks to developed healthcare infrastructure, rise in awareness among healthcare providers and patients about cancer diagnostics, and high investments in research and development. Additionally, the well-established healthcare sector has a wide range of technological solutions that support precision medicine and cancer treatments, which helps to treat cancer patients. Governments and companies in the North America region are investing heavily in research and development focused on diagnosis and treatment of cancer. The presence of the number of breast cancer patients in the developed countries like US and Canada are expected to drive the HER 2 testing Market Growth.
HER 2 testing Market Segmentation
By Product:
- Fluorescence in situ hybridization (FISH)
- Immunohistochemistry (IHC)
- Chromogenic in situ hybridization (CISH)
- Silver-enhanced in situ hybridization
Get Customization on this Report for Specific Research Solutions: https://www.maximizemarketresearch.com/request-customization/188548
By Cancer Type:
- Breast Cancer
- Gastric Cancer
- Bladder cancer
- Ovarian cancer
HER2 testing is used in breast cancer patients to control the presence or overexpression of the HER2 protein. The testing aids in recognizing patients who are eligible for targeted therapy with HER2-directed treatments. In 2020, there were more than 2.3 million women diagnosed with breast cancer globally. In the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 in men each year. HER2 positive cancers are expected to grow and spread faster over other types of breast cancer.
By End-User:
- Hospitals
- Diagnostic Laboratories
- Specialty Clinics
- Others
HER 2 testing Key Competitors include:
- Abbot
- Roche
- Agilent Technologies,Inc.
- Thermo Fisher Scientific Inc.
- Empire Genomics Inc.(Bio care Medical LLC)
- Abnova Corporation
- Oxford Gene Technology IP limited
- BCRF
- Genetech
- Genemed Technologies Inc.
- PERKINELMER Inc.
- QIAGEN
- BioDot
- BioGenex
Get the Sample PDF of Report: https://www.maximizemarketresearch.com/request-sample/188548
Key questions answered in the HER 2 testing Market are:
- What is HER 2 testing?
- What was the HER 2 testing Market Size in 2022?
- What is the expected HER 2 testing Market size during the forecast period?
- What are the global trends in the HER 2 testing Market?
- What are the major restraints for the HER 2 testing Market?
- Which segment dominated the HER 2 testing Market growth?
- What is the demand pattern for the HER 2 testing Market?
- What growth strategies are the players considering to increase their presence in the HER 2 testing Market?
- What are the upcoming industry applications and trends for the HER 2 testing Market?
- Who are the leading companies and what are their portfolios in HER 2 testing Market?
- Which region dominates the largest market share in HER 2 testing Market?
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2021)
- Past Pricing and price curve by region (2018 to 2021)
- Market Size, Share, Size & Forecast by different segment | 2022−2029
- Market Dynamics – Growth Drivers, Restraints, Opportunities and Challenges
- Market Segmentation – A detailed analysis by Product, Cancer Type, End-Users. Competitive Landscape – Profiles of selected key players by region from a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of Business by region
- Lucrative business opportunities with SWOT analysis
- Recommendations
Maximize Market Research is leading Healthcare research firm, has also published the following reports:
Bladder Cancer Treatment Market - Total Market size reached USD 4.06 Bn in 2022 and is expected to reach USD 7.52 Bn by 2029, growing at a CAGR of 9.2 % during the forecast period. The Technological advancements and availability of new treatment options Drive the Bladder cancer treatment Market.
Cancer Monoclonal Antibodies Market - The Total Market size was valued at USD 72.65 Bn in 2022 and is expected to reach USD 102.6 Bn by 2029, at a CAGR of 6 %. The incidence of cancer is increasing globally, which is driving the demand for cancer monoclonal antibodies.
Breast Cancer Drug Market - Total Market size was valued at USD 37.31 Billion in 2022 and the total Breast Cancer Drug revenue is expected to grow at a CAGR of 14.8% from 2023 to 2029, reaching nearly USD 98.04 Billion. The increased awareness of personalized medications, which rely on excised human tissue to generate a unique test for use in patient care, is driving up demand for excised human tissue.
Liver Cancer Diagnostics Market - The Total Market is expected to reach US $ 2.81 billion, thanks to growth in the industrial product segment. The report analyzes Liver Cancer Diagnostics Market dynamics by region and end-user industries. The laboratory tests category dominated the market for liver cancer diagnostics in 2021, accounting for 39.5 percent of total revenue.
Lung Cancer Surgery Market - Total Market was valued at US$ 27.23 Bn. in 2021, and it is expected to reach US$ 43.21 Bn. by 2029, exhibiting a CAGR of 5.94 % during the forecast period 2022-2029. Surgery for lung cancer is a treatment used to treat lung cancer, particularly non-small cell lung cancer.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include Healthcare, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research: 3rd Floor, Navale IT Park, Phase 2 Pune Banglore Highway, Narhe, Pune, Maharashtra 4120.4741, India sales@maximizemarketresearch.com +91 96071 95908, +91 9607365656
